ZCT.V Zero Candida Technologies Inc.
- Market cap
- CAD 2.73M
- P/E
- -
- P/B
- 2.97x
- ROE
- -74.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is ZCT.V undervalued?
Graham numberThe Graham number of Zero Candida Technologies Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zero Candida Technologies Inc. fundamental analysis
No fundamental analysis for Zero Candida Technologies Inc. yet.
Zero Candida Technologies Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zero Candida Technologies Inc.
Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.
Full company profileZero Candida Technologies Inc. financial statements
Zero Candida Technologies Inc. annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Income Statement | |||
| Revenue | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.52M | -2.24M | -1.29M |
| EBITDA | -2.51M | -6.14M | -1.03M |
| Net Income | -2.51M | -6.28M | -1.03M |
| EPS | -0.13 | -0.32 | -0.05 |
| Balance Sheet | |||
| Total Assets | 4.15K | 3.21M | 2.45M |
| Total Liabilities | 25.6K | 872K | 1.06M |
| Shareholders' Equity | -21.5K | 2.34M | 1.39M |
| Cash & Short-term Investments | 4.15K | 241K | 187K |
| Cash Flow | |||
| Operating Cash Flow | -669K | -940K | -740K |
| Capital Expenditure | 0.00 | 0.00 | 28.0K |
| Free Cash Flow | -669K | -940K | -768K |
| Ratios | |||
| ROE | - | -268.3% | -74.1% |
| ROA | -60,612.6% | -195.5% | -42.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Zero Candida Technologies Inc. dividends
Zero Candida Technologies Inc. has not paid dividends in the last 3 fiscal years.
Who owns Zero Candida Technologies Inc.
- Insiders 39.79%
- Institutions 0.00%
- Public & others 60.21%
- Shares outstanding 19.5M
Zero Candida Technologies Inc. company profile
- Company name
- Zero Candida Technologies Inc.
- Ticker
- ZCT.V
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Fiscal year end
- December
- Address
- 666 Burrard Street, Vancouver, BC, Canada, V6C 3P6
- Website
- zero-candida.com
About Zero Candida Technologies Inc.
Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.
Zero Candida Technologies Inc. management
5- Mr. Eli Ben-HarooshFounder, CEO & Director · born 1971
- Dr. Asher Holzer Ph.D.Co-Founder & Director · born 1950
- Dr. Irene Zaiton M.B.A., Ph.D.VP of Operations & Research
- Tammy Dvir Bar-OnVP Product & Marketing
- Yosh DolbergSenior VP of Development & Engineering